Cite

HARVARD Citation

    Joshi, S. et al. (2020). Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor. Pharmacology research & perspectives. 8 (6), p. n/a. [Online]. 
  
Back to record